WSI Co., Ltd. Stock

Equities

A299170

KR7299170001

Pharmaceuticals

End-of-day quote Korea S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
1,856 KRW -0.22% Intraday chart for WSI Co., Ltd. -0.80% -16.21%
Sales 2022 27.13B 19.61M Sales 2023 30.88B 22.32M Capitalization 66.51B 48.09M
Net income 2022 4.37B 3.16M Net income 2023 2.88B 2.08M EV / Sales 2022 1.39 x
Net cash position 2022 18.58B 13.43M Net Debt 2023 2.82B 2.04M EV / Sales 2023 2.25 x
P/E ratio 2022
15.8 x
P/E ratio 2023
29.1 x
Employees 27
Yield 2022 *
-
Yield 2023
-
Free-Float 30.25%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.22%
1 week-0.80%
Current month-6.03%
1 month-6.03%
3 months-14.27%
6 months-0.43%
Current year-16.21%
More quotes
1 week
1 839.00
Extreme 1839
1 909.00
1 month
1 811.00
Extreme 1811
2 010.00
Current year
1 811.00
Extreme 1811
2 645.00
1 year
1 750.00
Extreme 1750
2 645.00
3 years
1 505.00
Extreme 1505
3 515.00
5 years
1 505.00
Extreme 1505
5 800.00
10 years
1 505.00
Extreme 1505
5 800.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 20-11-16
Comptroller/Controller/Auditor 49 -
Members of the board TitleAgeSince
Chief Executive Officer 58 20-11-16
Director/Board Member 63 -
Director/Board Member 47 -
More insiders
Date Price Change Volume
24-04-30 1,856 -0.22% 39,533
24-04-29 1,860 -0.69% 58,967
24-04-26 1,873 +0.27% 41,160
24-04-25 1,868 -0.11% 33,061
24-04-24 1,870 -0.11% 49,059

End-of-day quote Korea S.E., April 29, 2024

More quotes
WSI Co Ltd, formerly IBKS No.10 Special Purpose Acquisition Co, is a Korea-based company mainly engaged in the sale of pharmaceuticals and medical devices. The Company mainly distributes the topical hemostatic agent Flosils. In addition, the Company supplies endoscopes related to spinal surgery, anti-adhesion agents, and bone hemostatic agents.
More about the company
  1. Stock Market
  2. Equities
  3. A299170 Stock